COVID’s Long-Term Impact On The Drug Supply Chain

This week, Stacey is joined by Chris Flask and they discuss how covid has impacted the drug supply chain, how the drug supply chain will look as we return to normal operations, and what the future has in store for this part of the industry.

Resources for this Episode:

1. New Bill Enacted Requiring Forecasting of Medical Device and Supply Shortages

2. FDA Drug Product Tracing Requirements – Overview

3. FDA Drug Product Tracing Requirements – The Bill

Chris Flask,

Global Business Capability Owner,

Roche Warehousing

With over 20 years in Pharma, Chris has held a variety of roles in Manufacturing, Strategic Development, and Supply Chain. All of these roles have required the development of Business Continuity Plans to ensure the continued supply of critical medicines to patients across the globe. Prior to his current role, Chris led the North America hub warehouse for Roche Drug Substance, managing the flow of $40 billion dollars worth of product annually.

Chris is currently the Global Business Capability Owner for Roche Warehousing. In this role, Chris is responsible for aligning the business processes used by over 60 warehouses worldwide. Chris holds a bachelor’s degree in Biochemistry from UCLA and a Master’s in Business Administration from UC Davis. Chris is a Black Belt in Lean/Six Sigma methodology and is Certified in Production Inventory Management by APICS.

Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.